You are here

Humira

After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge

Fierce Pharma

Sun, 02/25/24 - 08:57 pm

Teva Pharmaceutical

As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B

Fierce Pharma

Fri, 02/2/24 - 11:58 am

AbbVie’s Humira Maintains Market Dominance Amid Biosimilar Launches: Report

BioSpace

Thu, 01/18/24 - 11:30 am

The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup

Drug Channels

Tue, 01/9/24 - 09:41 am

Express Scripts

CVS to Remove AbbVie’s Humira from Reimbursement Lists, Cover Biosimilars

BioSpace

Thu, 01/4/24 - 10:18 am

Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System

Forbes

Mon, 12/4/23 - 10:14 am

FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars

Dermatology Times

Wed, 11/8/23 - 09:55 pm

Samsung Bioepis

AbbVie Stock Dives As Aesthetics Sales Mar Its Third-Quarter Beat And Guidance Boost

Investors Business Daily

Fri, 10/27/23 - 11:51 am

FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab

Generics Bulletin

Mon, 10/9/23 - 11:35 pm

interchangeability

Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar

Fierce Pharma

Wed, 10/4/23 - 11:21 am

Boehringer Ingelheim

Boehringer launches 81% discounted biosimilar of AbbVie's Humira

Reuters

Mon, 10/2/23 - 06:34 pm

Boehringer Ingelheim

unbranded biosimilars

Third Time Might Be a Charm for Alvotech as FDA Accepts BLA for Humira Biosimilar

BioSpace

Thu, 09/21/23 - 11:53 am

Alvotech gets new FDA review for Humira biosimilar

BioPharma Dive

Wed, 09/20/23 - 11:07 pm

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Medical Marketing and Media

Wed, 09/20/23 - 08:41 am

AbbVie’s Humira to Take Hit from Biosimilars, Next-Gen Therapies: Report

BioSpace

Fri, 09/8/23 - 11:29 am

Crohn's Disease

Amgen's hyped Humira biosimilar fritters away its exclusivity advantage

Fierce Pharma

Fri, 08/4/23 - 11:56 am

Despite big Q2 declines for Humira and Imbruvica, AbbVie still boosts earnings guidance

Fierce Pharma

Thu, 07/27/23 - 11:37 pm

Biosimilar makers split strategies in bid to take on top-selling Humira

BioPharma Dive

Thu, 07/27/23 - 10:25 am

Boehringer Ingelheim

Teva expands Alvotech collab with 2 more biosims, increased manufacturing oversight and a $40M investment

Fierce Pharma

Mon, 07/24/23 - 09:35 pm

Teva Pharmaceutical

drug manufacturing

Four Crucial Questions about the Humira Biosimilar Price War

Drug Channels

Tue, 07/18/23 - 11:38 am

Pages